Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease.

Neumann U, Ufer M, Jacobson LH, Rouzade-Dominguez ML, Huledal G, Kolly C, Lüönd RM, Machauer R, Veenstra SJ, Hurth K, Rueeger H, Tintelnot-Blomley M, Staufenbiel M, Shimshek DR, Perrot L, Frieauff W, Dubost V, Schiller H, Vogg B, Beltz K, Avrameas A, Kretz S, Pezous N, Rondeau JM, Beckmann N, Hartmann A, Vormfelde S, David OJ, Galli B, Ramos R, Graf A, Lopez Lopez C.

EMBO Mol Med. 2018 Sep 17. pii: e9316. doi: 10.15252/emmm.201809316. [Epub ahead of print]

2.

Development and validation of an ELISA at acidic pH for the quantitative determination of IL-13 in human plasma and serum.

Doucet J, Zhao A, Fu J, Avrameas A.

Dis Markers. 2013;35(5):465-74. doi: 10.1155/2013/290670. Epub 2013 Oct 2.

3.

Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.

Valentin MA, Ma S, Zhao A, Legay F, Avrameas A.

J Pharm Biomed Anal. 2011 Jul 15;55(5):869-77. doi: 10.1016/j.jpba.2011.03.033. Epub 2011 Mar 29.

PMID:
21530130
4.

A novel method for quantitative measurement of a therapeutic monoclonal antibody in the presence of its target protein using enzymatic digestion.

Doucet J, Avrameas A.

J Pharm Biomed Anal. 2010 Aug 1;52(4):565-70. doi: 10.1016/j.jpba.2010.01.033. Epub 2010 Jan 25.

PMID:
20149567
5.

Reduction of matrix interferences by the combination of chaotropic salt and DMSO in a broadly applicable target-based ELISA for pharmacokinetic studies of therapeutic monoclonal antibodies.

Doucet J, Canadi J, Kalis C, Valentin MA, Marrony S, Deckert-Salva F, Legay F, Avrameas A.

J Pharm Biomed Anal. 2009 Dec 5;50(5):924-31. doi: 10.1016/j.jpba.2009.06.029. Epub 2009 Jun 21.

PMID:
19608373
7.

Efficient gene delivery by a peptide derived from a monoclonal anti-DNA antibody.

Avrameas A, Ternynck T, Gasmi L, Buttin G.

Bioconjug Chem. 1999 Jan-Feb;10(1):87-93.

PMID:
9893969
8.

Immunochemical, structural and translocating properties of anti-DNA antibodies from (NZBxNZW)F1 mice.

Ternynck T, Avrameas A, Ragimbeau J, Buttin G, Avrameas S.

J Autoimmun. 1998 Oct;11(5):511-21.

PMID:
9802938
9.
10.

Mimotopes of polyreactive anti-DNA antibodies identified using phage-display peptide libraries.

Sibille P, Ternynck T, Nato F, Buttin G, Strosberg D, Avrameas A.

Eur J Immunol. 1997 May;27(5):1221-8.

PMID:
9174614
11.

Expression of a mannose/fucose membrane lectin on human dendritic cells.

Avraméas A, McIlroy D, Hosmalin A, Autran B, Debré P, Monsigny M, Roche AC, Midoux P.

Eur J Immunol. 1996 Feb;26(2):394-400.

PMID:
8617309
12.

Comparison of serological tests for the diagnosis of feline immunodeficiency virus infection of cats.

Sibille P, Avraméas A, Moraillon A, Richardson J, Sonigo P, Pancino G, Strosberg AD.

Vet Microbiol. 1995 Jul;45(2-3):259-67.

PMID:
7571377
13.

Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins.

Avrameas A, Strosberg AD, Moraillon A, Sonigo P, Pancino G.

Res Virol. 1993 May-Jun;144(3):209-18.

PMID:
7689247
14.

Localisation of three epitopes of the env protein of feline immunodeficiency virus.

Avrameas A, Guillet JG, Chouchane L, Moraillon A, Sonigo P, Strosberg AD.

Mol Immunol. 1992 May;29(5):565-72.

PMID:
1374840

Supplemental Content

Loading ...
Support Center